BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9667442)

  • 1. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years.
    Lee AY
    Contact Dermatitis; 1998 May; 38(5):258-60. PubMed ID: 9667442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provocation tests in a chlormezanone-induced fixed drug eruption.
    Lee AY; Lee YS
    DICP; 1991 Jun; 25(6):604-5. PubMed ID: 1831577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption.
    Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
    Contact Dermatitis; 1999 Oct; 41(4):185-9. PubMed ID: 10515095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of patch testing for patients with drug eruption.
    Ohtoshi S; Kitami Y; Sueki H; Nakada T
    Clin Exp Dermatol; 2014 Apr; 39(3):279-83. PubMed ID: 24635061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug eruptions: the value of oral rechallenge test and patch test.
    Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
    J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical provocation of fixed drug eruption. A study of 30 patients.
    Alanko K
    Contact Dermatitis; 1994 Jul; 31(1):25-7. PubMed ID: 7924289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing.
    Zedlitz S; Linzbach L; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2002 Jun; 46(6):352-3. PubMed ID: 12190624
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical provocation in fixed drug eruption due to metamizol and naproxen.
    Ozkaya-Bayazit E
    Clin Exp Dermatol; 2004 Jul; 29(4):419-22. PubMed ID: 15245546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical provocation of fixed drug eruption due to sulphamethoxazole.
    Oleaga JM; Aguirre A; González M; Diaz-Pérez JL
    Contact Dermatitis; 1993 Sep; 29(3):155. PubMed ID: 8222629
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed drug eruption.
    Gómez B; Sastre J; Azofra J; Sastre A
    Allergol Immunopathol (Madr); 1985; 13(2):87-91. PubMed ID: 3159244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical provocation of fixed drug eruption.
    Alanko K; Stubb S; Reitamo S
    Br J Dermatol; 1987 Apr; 116(4):561-7. PubMed ID: 2953388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch testing in fixed drug eruptions--a 20-year review.
    Andrade P; Brinca A; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):195-201. PubMed ID: 21702758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole.
    Kai Y; Okamoto O; Fujiwara S
    Clin Exp Dermatol; 2011 Oct; 36(7):755-8. PubMed ID: 21933233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous reactions to drugs: a series of in-patients during a five-year period.
    Stubb S; Heikkilä H; Kauppinen K
    Acta Derm Venereol; 1994 Jul; 74(4):289-91. PubMed ID: 7976089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
    Tornero P; De Barrio M; Baeza ML; Herrero T
    Contact Dermatitis; 2004 Aug; 51(2):57-62. PubMed ID: 15373844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis.
    Short KA; Fuller LC; Salisbury JR
    Clin Exp Dermatol; 2002 Sep; 27(6):464-6. PubMed ID: 12372086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed drug eruption from sodium benzoate.
    Vilaplana J; Romaguera C
    Contact Dermatitis; 2003 Dec; 49(6):290-1. PubMed ID: 15025701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed drug eruption in Bangladeshi population: confirmed by provocative test.
    Rahman MH
    Int J Dermatol; 2014 Feb; 53(2):255-8. PubMed ID: 23968227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-induced fixed drug eruption: positive topical provocation on previously involved and uninvolved skin.
    Ozkaya-Bayazit E; Güngör H
    Contact Dermatitis; 1998 Aug; 39(2):87-8. PubMed ID: 9746194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.